FIELD: biotechnology; molecular biology.
SUBSTANCE: described is a set of oligodeoxyribonucleotide primers for determining microRNA hsa-miR-143-5p by real-time quantitative polymerase chain reaction. Also described is the use of said set for diagnosing cardiovascular diseases and detecting the risk of their development based on the biomolecular microRNA marker hsa-miR-143-5p.
EFFECT: wider range of products for diagnosing cardiovascular diseases and determining risk of their development.
3 cl, 4 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SET OF OLIGODEOXYRIBONUCLEOTIDE PRIMERS FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT BASED ON BIOMOLECULAR MARKER microRNA hsa-miR-145-3p BY QUANTITATIVE PCR AND USE THEREOF | 2025 |
|
RU2838260C1 |
| SET OF OLIGODEOXYRIBONUCLEOTIDE PRIMERS FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT BASED ON BIOMOLECULAR MARKER microRNA hsa-miR-143-3p BY QUANTITATIVE PCR AND USE THEREOF | 2025 |
|
RU2838257C1 |
| RECOMBINANT PLASMID DNA CODING microRNA hsa-miR-143-5p, AND ITS USE AS POSITIVE CONTROL IN REAL-TIME PCR FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT | 2025 |
|
RU2837872C1 |
| RECOMBINANT PLASMID DNA CODING microRNA hsa-miR-145-5p, AND ITS USE AS POSITIVE CONTROL IN REAL-TIME PCR FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT | 2025 |
|
RU2837874C1 |
| RECOMBINANT PLASMID DNA CODING microRNA hsa-miR-143-3p, AND ITS USE AS POSITIVE CONTROL IN REAL-TIME PCR FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT | 2025 |
|
RU2837882C1 |
| RECOMBINANT PLASMID DNA CODING microRNA hsa-miR-145-3p, AND ITS USE AS POSITIVE CONTROL IN REAL-TIME PCR FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT | 2025 |
|
RU2837873C1 |
| METHOD FOR PREDICTION OF RECURRENT MISCARRIAGE BY MICRORNA GENE EXPRESSION IN ENDOMETRIAL BIOPSY MATERIAL | 2025 |
|
RU2837879C1 |
| REAGENT KIT FOR DETECTING SMALL RIBONUCLEIC ACIDS (microRNA) IN DIAGNOSING MULTIPLE MYELOMA | 2024 |
|
RU2836054C1 |
| TEST SYSTEM “miR-M-SCREEN” FOR PREDICTING THE DEVELOPMENT OF METASTASES IN PATIENTS WITH COLORECTAL CANCER BASED ON THE LEVEL OF miR-26a AND miR-143 MICRO-RNA IN BLOOD PLASMA | 2022 |
|
RU2786386C1 |
| OLIGONUCLEOTIDES FOR DIAGNOSING EPILEPSY BY QUANTITATIVE PCR | 2023 |
|
RU2815113C1 |
